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Objective: Asthma is the most common chronic disease in children. Previous studies described
significant variations in acute asthma management in children. This study was conducted to
examine whether asthma management in the pediatric emergency department (ED) was
improved through the use of an evidence-based acute asthma care guideline reminder card.
Methods: The Pediatric Acute Asthma Management Guideline (PAMG) was introduced to the ED
of a pediatric tertiary care hospital in Ontario, Canada. Medical charts of 278 retrospective ED
visits (JanuaryeDecember 2002) and 154 prospective visits (July 2003eJune 2004) were
reviewed to assess changes in acute asthma management such as medication treatment,
asthma education, and discharge planning. Logistic and linear regressions were used to deter-
mine the effect of PAMG on asthma management in the ED. The propensity score method was
used to adjust for confounding.ientist and Program Head, Child Health Evaluative Sciences, Research Institute, The Hospital for Sick
nto, Ontario, M5G 1X8, Canada. Tel.: þ1 416 813 8498; fax: þ 1 416 813 5979.
.ca (T. To).
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1264 T. To et al.Results: During the implementation of PAMG, patients who visited the ED were more likely to
receive oral corticosteroids (Adjusted Odds Ratio [AOR]Z 2.26, 95% CI: 1.63e3.14, p < 0.0001)
and oxygen saturation reassessment before ED discharge (AOR Z 2.02, 95% CI: 1.45e2.82,
p < 0.0001). They also received 0.23 (95% CI: 0.03e0.44, pZ 0.0283) more doses of broncho-
dilator in the first hour of ED stay. Improvements in asthma education and discharge planning
were noted, but the changes were not statistically significant.
Conclusions: After the implementation of an evidence-based guideline reminder card, medica-
tion treatment for acute asthma in the ED was significantly improved; however, asthma educa-
tion and discharge planning remained unchanged. Future efforts on promoting guideline-based
practice in the ED should focus on these components.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Asthma is the most common chronic disease in children. In
Canada, according to the National Longitudinal Survey of
Children and Youth, the prevalence of asthma in children
under 12 years old was 11.2%.1 Using the health adminis-
trative databases in Ontario, To et al. reported a preva-
lence of 19.6% in children under 10 years of age.2 A recent
population-based study in Ontario showed that one in ten
children with asthma had an ED visit for asthma over a two-
year period, and that 5.6% of those discharged from the ED
had a return visit within 72 h3 Although asthma-related
deaths have decreased substantially in recent years,
emergency department (ED) visits and hospital admissions
for asthma remain significant,1,3e5 representing a heavy
burden of illness in young children and an increasing
economic pressure for the health care system.
Several Canadian and US studies have described signifi-
cant regional variations in hospitalization rates for child-
hood asthma since the 1990s,4,6e13 which are largely
influenced by variations in patient characteristics and/or
asthma management in emergency departments (EDs).12,14
While many guidelines exist for the management of acute
asthma in children,15e21 substantial practice variations still
persist.22,23 These findings call for a systematic approach to
acute asthma management in order to reduce practice
variations and uncertainties in treatment and improve
patient outcomes.
The Pediatric Acute Asthma Management Guideline
(PAMG) reminder card is an evidence-based management
tool based on the Canadian Asthma Consensus Guide-
lines.15e17 The objective of this study was to examine
whether asthmamanagement in theEDof apediatric tertiary
care hospital was improved through the use of PAMG.
Methods
Setting
This study was conducted at the Emergency Department (ED)
at The Hospital for Sick Children in Toronto, Canada. The
Hospital for Sick Children is the primary care pediatric
hospital for the downtown core of Toronto and the tertiary
pediatric referral centre for the Greater Toronto Area. Its ED
provides care to approximately 50,000 children each year,
with almost 6000 of those children admitted from the ED to
inpatient care. The ED is also a training site for a large numberof medical trainees (over 250 each year); from medical
students to fifth year emergency medicine residents.
Evidence-based acute asthma care Guideline
reminder card
The Pediatric Acute Asthma Management Guideline (PAMG)
wasdevelopedby the investigator teamconsistingofpediatric
respirologist, pediatric emergency physicians and nurse
practitioners based on Canadian Asthma Consensus Guide-
lines.15e17 It was disseminated in the form of a pocket-size
reminder card (Fig. 1), each of which cost approximately 70
cents (CAD) to produce. It includes five sections: initial
assessment, medications and tests, reassessment and moni-
toring, disposition, and education and discharge planning.
PAMG was introduced to all health care providers
(including physicians, nurses, residents and respiratory ther-
apists) at the ED of The Hospital for Sick Children in Toronto,
Canada after January 2003 through multiple presentations at
their rounds and business meetings. Methods of disseminating
PAMG included: 1) providing an ample supply of the reminder
card for use at the ED; and 2) distributing individual packages
(with a short description of the study and the reminder card)
to the ED staff in their mailboxes.
Study design and procedure
Medical charts of ED visits for acute asthma before and
during the implementation of PAMG were reviewed by one
trained chart abstractor using the same chart abstraction
form with clear variable definitions and abstraction guide-
lines. The chart abstractor was a coordinator of the study
and was aware of the study hypothesis and the subject
status. An acute asthma episode was defined as the sudden
worsening of symptoms resulting in difficulty in breathing
that often required taking extra medicine to relieve asthma
symptoms.24,25 The final diagnosis of asthma was deter-
mined by the attending physician at the ED.
In both retrospective and prospective groups, children
were excluded if they had an uncertain diagnosis of asthma
(e.g. children with a first time wheeze and without a strong
family history of asthma), a primary diagnosis of pneu-
monia, significant co-morbid conditions (e.g. foreign body
airway obstruction, congenital heart disease, broncho-
pulmonary dysplasia, significant neurologic impairment), or
severe respiratory distress with altered mental status or
respiratory acidosis. In order to assess asthma education
Figure 1 The Pediatric Acute Asthma Management Guideline Reminder Card.
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inpatient ward (60 from the prospective group and 29 from
the retrospective group) were excluded from the analysis
for this paper. In order to minimize the impact of the
outbreak of Severe Acute Respiratory Syndrome (SARS) on
the study results, children who visited the ED between
January and June 2003 were also excluded.
The prospective group consisted of children aged 2e17
years (inclusive) who visited the ED between July 2003 and
June 2004. Two research assistants who worked in the ED on
rotating schedules approached eligible parents (if child
aged 15 years or younger) or children (if child aged 16 years
or older) visiting the ED for respiratory problems for the
consent process. Once consent was obtained, the research
assistants interviewed the parents/children using a stan-
dardized survey to collect information on socio-demo-
graphic characteristics, asthma control and asthma
self-management. Details of the study procedure have been
published elsewhere.25 Although a prospective survey was
conducted in the prospective group, only chart abstraction
data were used for this analysis.
The retrospective group consisted of children who
visited the ED for acute asthma at the same institution one
year prior to the implementation of PAMG (between
January and December 2002). Demographic information of
all ED visits for acute asthma (ICD-9 code: 493; ICD-10
codes: J45 and J46) during this period was provided by
Health Records. Age- and sex- stratified random sampling of
these ED visits were performed to select patients with
similar age and sex distribution compared to the prospec-
tive group with a ratio of approximately 2:1 (retrospectivevs. prospective). Since one patient could have multiple ED
visits, for the purpose of this study only the first ED visit
within the retrospective sampling period were used.
A total of 278 retrospective and 154 prospective ED visits
were included in the final analysis. A total of 17 charts were
abstracted twice by the trained chart abstractor. The intra-
rater reliability was 97.5% on all as well as key outcome
variables. The study was approved by the Research Ethics
Board at The Hospital for Sick Children.
Data collection
Patient data were abstracted from the medical charts.
They included age, gender, history of ED visit or hospitali-
zation for asthma, date and time of current ED visit,
characteristics of current acute asthma episode (e.g.,
symptoms, signs, and oxygen saturation [SaO2] recorded by
pulse oximetry at presentation), management of acute
asthma in the ED (e.g., oxygen therapy, medications, and
laboratory tests), and length of ED stay.
Outcome measures
The primary outcomes of interest for this study were
administration of systemic corticosteroids and bronchodila-
tors during ED stay, asthma education (e.g., dissemination of
asthma information package, education on use of inhalation
equipment, and review of asthma triggers) in the ED, and
discharge planning (e.g., instructions on follow-up appoint-
ment and prescriptions of oral and inhaled corticosteroids).
1266 T. To et al.Other outcomes, including treatment processes (e.g., time
from entry to the ED to bronchodilator treatment) and
reassessment of asthma status (i.e., symptoms, signs, and
SaO2) before discharge, were also compared between the
retrospective and prospective groups.
Statistical analysis
Patients’ age, gender, history of ED visit or hospitalization for
asthma, characteristics of the acute asthma episode, and
acute asthma management in the ED were compared
between the retrospective and prospective groups, using the
chi-square test for nominal data and the Student’s t-test for
continuous variables. To examine the stability in clinical
practice pattern before the implementation of PAMG, acute
asthmamanagement in the ED was analyzed quarterly in the
retrospective period (i.e., JanuaryeDecember 2002).
Since univariate analyses showed significant differences
in patient characteristics between the retrospective and
prospective groups, which can lead to biased estimates of
intervention effects, we used the propensity score method
to account for potential confounding effects.26 The
propensity score, defined as the conditional probability of
being treated given the covariates, can be used to balance
the covariates in the two groups, and therefore reduce this
bias.26 In order to estimate the propensity score, multivar-
iable logistic regressions were used to calculate the condi-
tional probability of a patient being selected for each
treatment, given the pre-treatment characteristics
including age, gender, history of ED visit/hospitalization for
asthma, presence of symptoms and signs, SaO2 at initial
presentation, length of stay, season of ED visit, day of EDTable 1 Characteristics of study population.
Characteristics Retrospective
n
Age <7 years 186
Male 174
History of ER visit/hospitalization for asthma 74
Visited ED in spring/fall 144
Visited ED on weekdays 198
Visited ED during day time (8am-7pm) 158
Length of stay in ED (hours, Mean  SD) 6.6  6.6
SaO2 at presentation (%)




Asthma symptoms at presentation




Physical signs at presentation
Observed difficulty in breathing 35
Use of accessory muscles 142
Wheeze 208
Note: All percentages have been adjusted for missing data.visit, and hour of ED visit. Multivariable logistic and linear
regressions were then used to determine the impact of PAMG
on acute asthma management in the ED while adjusting for
the propensity scores. Statistical Analysis Systems (SAS)
software 9.127 was used to conduct all analyses.
Results
Characteristics of study population
Table 1 showed that the prospective and retrospective
groups were not statistically different in demographic char-
acteristics and SaO2 at presentation (95.5%  2.7% versus
95.9%  3.4%, pZ 0.2463). Compared to the retrospective
group, patients in the prospective group were more likely to
visit the EDonweekdays (90.9% versus 71.2%, p< 0.0001) and
during day time (68.2% versus 56.8%, pZ 0.0235), to present
with wheeze (91.5% versus 75.4%, p< 0.0001) and accessory
muscles use (71.9% versus 51.4%, p < 0.0001) on physical
examination, and to have increased length of ED stay
(8.6  7.7 versus 6.6  6.6 h, pZ 0.0163).
Acute asthma management in ED before and after
implementation of PAMG
Table 2 showed that the proportions of patients who received
various treatments in the ED were significantly higher in the
prospective group. For example, they were more likely to
receive supplemental oxygen (9.7% versus 3.2%, pZ 0.0074),
salbutamol (96.8% versus 83.1%, p < 0.0001), ipratropium
bromide (77.3% versus 66.2%, p Z 0.0161), and oralNZ278 Prospective NZ154 p-value
% n %
66.9 107 69.5 0.5930
62.6 91 59.1 0.5361
26.6 49 31.8 0.2668
51.8 80 51.9 1.0000
71.2 140 90.9 < 0.0001
56.8 105 68.2 0.0235
8.6  7.7 0.0163
95.5  2.7 0.2463
60.4 83 55.0 0.1561
33.5 53 35.1
6.2 15 9.9
60.4 102 66.7 0.2120
35.6 71 46.4 0.0307
87.6 135 88.2 1.0000
5.1 8 5.2 1.0000
12.7 30 19.6 0.0673
51.4 110 71.9 <0.0001
75.4 140 91.5 <0.0001
Table 2 Acute asthma management in ED before and after implementation of PAMG.
Asthma Management in ED Retrospective NZ278 Prospective NZ154 p-value
n % n %
Documentation in Medical Chart
History of ED visit/hospitalization for asthma 168 60.4 116 75.3 0.0021
SaO2 at presentation 260 93.9 151 98.1 0.0559
SaO2 reassessment before discharge 141 50.7 110 71.4 < 0.0001
Treatments and Tests in ED
Oxygen 9 3.2 15 9.7 0.0074
Salbutamol
Number of doses (Mean  SD)
In first hour 2.0  0.9 2.3  0.9 0.0004
In first 4 h 3.1  1.5 3.6  1.4 0.0031
Over ED stay 3.7  2.3 4.6  2.5 0.0005
Any 231 83.1 149 96.8 < 0.0001
Ipratropium bromide
Number of doses (Mean  SD)
In first hour 2.0  1.0 2.3  0.9 0.0035
In first 4 h 2.6  1.0 2.7  0.9 0.3698
Over ED stay 2.7  1.1 2.8  1.1 0.2790
Any 184 66.2 119 77.3 0.0161
Salbutamol combined with ipratropium bromide
in patient with initial SaO2  95%
90 87.4 59 86.8 1.0000
Oral corticosteroids 167 60.1 129 83.8 < 0.0001
Chest x-ray 68 24.5 46 29.9 0.2545
Time between Processes (Minutes, Mean  SD
Entry of ED to bronchodilator treatment 62.9  66.5 78.8  76.0 0.0334
Entry of ED to corticosteroid treatment 142.7  88.6 125.0  87.1 0.0901
Bronchodilator treatment to physical exam reassessment 52.0  40.8 57.1  47.9 0.3162
Bronchodilator to SaO2 reassessment 90.7  95.4 94.6  75.1 0.7258
Asthma Education during ED Stay
Assessed educational needs 18 6.5 3 1.9 0.0370
Addressed questions/concerns of child and family 56 20.1 32 20.8 0.9011
Disseminated asthma information package 53 19.1 28 18.2 0.8978
Educated on use of inhalation equipment 81 29.1 47 30.5 0.8260
Reviewed asthma triggers 11 4.0 6 3.9 1.0000
At least one of above 88 31.9 53 34.4 0.5940
Discharge Conditions
Gooda 142 93.4 86 96.6 0.3825
SaO2 > 95% at last assessment 99 70.2 74 67.3 0.6806
Discharge planning
Received instructions on follow-up appointment 196 70.5 121 78.6 0.0705
Received arrangement for referral to specialist 4 1.4 4 2.6 0.4636
Prescribed oral corticosteroids 158 56.8 107 69.5 0.0101
Prescribed inhaled corticosteroids 187 67.3 106 68.8 0.7485
Note: All percentages have been adjusted for missing.
a As indicated by ED physicians on the medical chart based on overall patient assessment at discharge.
Using a guideline reminder card to improve asthma care 1267corticosteroids (83.8% versus 60.1%, p < 0.0001). They also
received more doses of salbutamol during their ED stay
(4.6  2.5 versus 3.7  2.3, p Z 0.0005). Significant
improvements also occurred in the prospective group in the
documentationof previous EDvisit/hospitalization for asthma
(75.3% versus 60.4%, pZ 0.0021) and reassessment of oxygen
saturation before discharge (71.4% versus 50.7%, p< 0.0001).
At discharge, oral corticosteroids were more commonly
prescribed in the prospective group (69.5% versus 56.8%,pZ 0.0101) compared to the retrospective group. However,
there was no statistical difference between the two groups in
the percentage of patients who received inhaled corticoste-
roids prescription (68.8% versus 67.3%, p Z 0.7485), asthma
education (34.4% versus 31.9%, pZ 0.5940), and instruction
on follow-up visit (78.6% versus 70.5%, pZ 0.0705).
Compared to the retrospective group, it took longer for
patients in the prospective group to receive bronchodilator
treatment (78.8  76.0 versus 62.9  66.5 min, pZ 0.0334)
1268 T. To et al.after entry to the ED. There was no statistical differences
between the timingof receivingoral corticosteroids between
the two groups (125.0  87.1 versus 142.7  88.6 min,
pZ 0.0901).
Analyses of acute asthma management on a quarterly
basis in the retrospective period showed no obvious
changes in clinical practice pattern over time before the
implementation of PAMG (data not shown).
Effect of PAMG on acute asthma management in ED
Table 3 showed results of multiple regression models
adjusted for the propensity score of a patient being given
each treatment. Compared to the retrospective group,
patients in the prospective group received an average of
0.23 (95% CI: 0.03e0.44, p Z 0.0283) more doses of
salbutamol in the first hour during the ED stay. Their odds of
receiving oral corticosteroids (Adjusted Odds Ratio
[AOR] Z 2.26, 95% CI: 1.63e3.14, p < 0.0001) and SaO2
reassessment before ED discharge (AOR Z 2.02, 95% CI:
1.45e2.82, p < 0.0001) were also twice as high compared
to the retrospective group. Regression analyses showed
that the implementation of PAMG did not affect asthma
education, follow-up instructions, or oral corticosteroids
prescription at ED discharge (data not shown).
Discussion
Our study showed that disseminating a pocket-size acute
asthma care guideline reminder card in the ED of a pedi-
atric tertiary care center can promote guideline-based
acute asthma management in children, including more
aggressive medication treatment and better documenta-
tion of clinical assessments.
One significant gap in acute asthma management in chil-
dren that has been identified is under-prescription of systemic
corticosteroids.13,22,28 Guidelines recommend administration
of systemic corticosteroids as early as possible during ED
encounters for acute asthma to speed the resolutionof airflow
obstruction andprevent early relapse.15,20 Compared to other
hospitals in Ontario,22 the use of systematic corticosteroids at
our institution was already high in the retrospective group
(i.e., pre-intervention period). This is understandable since
our hospital is a tertiary care teaching hospital, where moreTable 3 Effect of PAMG (prospective vs. retrospective) on acut
Asthma Management in ED Unadjusted
Logistic Regression ORb 95%
Systematic corticosteroids given in ED 3.11 1.8
SaO2 reassessed before discharge 2.14 1.3
Linear Regression bc 95%
Number of salbutamol doses given in first hour 0.22 0.0
CI: confidence intervals.
a All models were adjusted for the propensity score (or conditional
the pre-treatment characteristics including age, gender, history of
accessory muscles, SaO2 at initial presentation, length of stay, seaso
b OR: Odds ratio (prospective versus retrospective group) was estim
c Regression coefficient b (prospective versus retrospective group
increase in the number of salbutamol doses in the prospective groupcomplicated asthma patients may be referred from commu-
nity health care providers. Nevertheless, there was still
substantial room for improvement compared to guideline
recommendations. While the characteristics of asthma
exacerbations and ED visits at our institutionmay be different
from other community hospitals and may have changed
slightly over time (between the retrospective and prospective
groups), results of our adjustedanalyses showed that systemic
corticosteroids were still administered more often during the
ED stay in the prospective group (i.e., after the imple-
mentation of PAMG).
In addition to short-term preventive care, significant
improvements were also observed in symptomatic care for
acute asthma in the prospective group, including more
frequent useof bronchodilators in thefirst hour after entry to
the ED. However, the wait time from entry to the ED to
bronchodilator treatment was over 60 min in both groups.
This delay may be attributable to ED crowding and shortage
of ED staff. Therefore, appropriate resource allocation and
efforts to improve the functioning of the health care team,
such as standing orders that allow nurses to administer the
medication without waiting for physicians’ instructions, may
improve the timing to the first medication treatment at EDs.
While EDs play a major role in managing acute asthma
exacerbations, they may also have an important role in
bridging theacute and long-termcare systems to improve the
continuity of care for asthma patients.29 Current guidelines
suggest that proper asthma education and discharge plan-
ning should be given to patients before ED discharge to
reduce short-term readmission rates and improve long-term
asthma management.15,18,20 Components of asthma educa-
tion and discharge planning may include review of medica-
tions (including inhaler technique) and environmental
control measures, review/initiation of an action plan and
inhaled corticosteroids, and recommendation on scheduled
medical follow-up. However, many barriers, such as the
allocation of adequate staff time for patient education,
adjustment of content to meet individual patients’ needs,
and the assessment of learners’ comprehension,30 often
exist andmake it difficult to implement or document asthma
education activities. Similar to other studies,22,31 our results
showed that the majority of patients did not receive asthma
education before discharge, and that one in four patients left
the ED without instructions on follow-up visit with their
primary care provider or prescriptions of oral and inhalede asthma management in ED (N Z 309).
Adjusteda
CI p-value OR 95% CI p-value
2e5.30 <0.0001 2.26 1.63e3.14 < 0.0001
4e3.42 0.0016 2.02 1.45e2.82 < 0.0001
CI p-value b 95% CI p-value
7e0.37 0.0410 0.23 0.03e0.44 0.0283
probability) of a patient being selected for each treatment, given
ED visit/hospitalization for asthma, presence of wheeze, use of
n of ED visit, day of ED visit, and hour of ED visit.
ated using logistic regression.
) was estimated using linear regression. b equals the average
.
Using a guideline reminder card to improve asthma care 1269corticosteroids. Using a pre- and post- design, Mackey and
colleagues examined the effect of an asthma care map on
patient management in the ED and also found inconsistent
and infrequent use of the discharge planning section by
physicians.28 These findings call for further improvements in
providers’ efforts on asthma education and discharge plan-
ning in the ED.
Several limitations of this study should be noted. First,
without a randomized controlled trial, it would be diffi-
cult to assess the possible influence of clinical advances
or other system changes on the effects we observed. In
the current study, it also was possible that physicians in
the prospective study period were aware that they were
being evaluated and therefore documented clinical
processes more vigorously. Second, all medical charts
were reviewed by one chart abstractor who was not
blinded to the study hypothesis and the subject status.
This is the most common limitation in medical record
review studies in emergency medicine32 and could have
introduced bias to the study results. To minimize this
bias, standard chart abstraction form with clear variable
definitions and abstraction guideline was used in the
current study. Third, our study cohort was a non-random
sample of patients who attended the ED of a tertiary
children’s hospital. So our findings may not be general-
izable to patients managed in EDs in community setting.
Finally, providers may not document all clinical activities
in the medical charts, and therefore discrepancies
between medical chart review and clinical care provided
to patients may exist and could have influenced the val-
idity of chart abstraction data, especially on asthma
educational activities.33 However, it has been shown that
compared to directly observed care, medical chart
review was more accurate on certain key aspects of
assessment (e.g., oxygen saturation) and treatment (e.g.,
oral corticosteroids prescribed at discharge) in the ED.33
Conclusion
This study provides evidence that treatment of acute
asthma exacerbations in children in the ED was improved
after the implementation of an evidence-based manage-
ment tool (i.e., a guideline reminder card). Regular
updates of the management tool based on the latest
guidelines and financial support for its on-going production
are key to the sustainability of this strategy. Despite the
use of an evidence-based guideline protocol, asthma
education and discharge planning at our ED remained
unchanged. Strengthening asthma education and discharge
planning as suggested by others34e36 may improve the low
follow-up rates with primary care physicians after ED
discharge.22,25. Future efforts should focus on promoting
and improving evidence-based practice of these compo-
nents of asthma management in acute care settings.
Conflict of interest statement
None of the authors was an employee of the pharmaceu-
tical companies funding this project and none had received
any salary support from them. None of the authors has
conflicts of interest to disclose.Acknowledgement
The principle of this study was supported and approved by
the Ontario Ministry of Health e Drug Utilization Advisory
Council. Funding was provided to Dr. Teresa To by Altana
Pharma Inc, GlaxoSmithKline Inc, and Merck Frosst Canada
Ltd. Dr. Teresa To is supported by the University of Toronto,
Life Sciences Committee, Dales Award in Medical Research.
References
1. Millar WJ, Hill GB. Childhood asthma. Health Rep 1998;10(3):
9e21.
2. To T, Dell S, Dick P, et al. Burden of childhood asthma: ICES
investigative report. Toronto; May 2004.
3. Guttmann A, Zagorski B, Austin P, et al. Effectiveness of
emergency department asthma management strategies on
return visits in children: a population-based study. Pediatrics
2007;120(6):e1402ee1410.
4. To T, Dick P, Feldman W, Hernandez R. A cohort study on
childhood asthma admissions and readmissions. Pediatrics
1996;98(2):191e5.
5. To T, Gershon A, Tassoudji M, et al. The burden of asthma in
Ontario: ICES investigative report. Toronto; Sep 2006.
6. Wilkins K, Mao Y. Trends in rates of admission to hospital and
death from asthma among children and young adults in Canada
during the 1980s. CMAJ 1993;148(2):185e90.
7. Weitzman M, Gortmaker S, Sobol A, Perrin J. Recent trends in
the prevalence and severity of childhood asthma. JAMA 1992;
268(19):2673e7.
8. To T, Dick P, Feldman W, Tran M. Pediatric health service utiliza-
tion: hospitalization for childhood asthma. In: Goel V,Williams JI,
Anderson GM, Blackstien-Hirsch P, Fooks C, Naylor CD, editors.
Patterns of health care in ontario. The ICES practice Atlas, vol. 2.
Ottawa: Canadian Medical Association; 1996. p. 307e9.
9. Johansen H, Dutta M, Mao Y, Chagani K, Sladecek I. An inves-
tigation of the increase in preschool-age asthma in Manitoba,
Canada. Health Rep 1992;4(4):379e402.
10. Senthiselvan A. Trends and rural-urban differences in asthma
hospitalizations in Saskatchewan 1970e1989. Can Respir J
1995;1(4):229e34.
11. Editorial Board Respiratory Disease in Canada. Respiratory
disease in Canada. Ottawa, ON, Sep 2001. H39e593/2001E.
12. Lougheed DM, Garvey N, Chapman KR, et al. The ontario
asthma regional variation study: emergency department visit
rates and the relation to hospitalization rates. Chest 2006;129
(4):909e17.
13. Rowe BH, Bota GW, Clark S, Camargo CA. Comparison of
Canadian versus american emergency department visits for
acute asthma. Can Respir J 2007;14(6):331e7.
14. Legorreta AP, Christian-Herman J, O’Connor RD, Hasan MM,
Evans R, Leung K-M. Compliance with national asthma manage-
ment guidelines and special care. A health maintenance orga-
nization experience. Arch Intern Med 1998;158:457e64.
15. Boulet LP, Becker A, Berube D, Beveridge R, Ernst P. Canadian
asthma consensus group. Canadian asthma consensus report,
1999. Can Med Assoc J Nov 30 1999;161(Suppl. 11):S1eS61.
16. Becker A, Lemiere C, Berube D, et al. Summary of recom-
mendations from the Canadian asthma consensus guidelines,
2003. CMAJ Sep 13 2005;173(Suppl. 6):S3eS11.
17. Becker A, Berube D, Chad Z, et al. Canadian pediatric asthma
consensus guidelines, 2003 (updated to december 2004):
introduction. CMAJ Sep 13 2005;173(Suppl. 6):S12eS14.
18. Global Initiative for Asthma (GINA). Global strategy for asthma
management and prevention, http://www.ginasthma.com
[accessed 19.01.09].
1270 T. To et al.19. British Thoracic Society, Scottish Intercollegiate Guidelines
Network. British guideline on the management of asthma:
a national clinical guideline. London, May 2008.
20. National Asthma Education and Prevention Program (NAEPP)
Coordinating Committee. NAEPP Expert Panel Report 3:
Guidelines for the diagnosis and management of asthma 2007.
21. National Asthma Council Australia. Asthma management
handbook 2006. Melbourne, 2006.
22. Lougheed MD, Garvey N, Chapman KR, et al. Variations and
gaps in management of acute asthma in ontario emergency
departments. Chest; Nov 18 2008.
23. Tsai CL, Sullivan AF, Gordon JA, et al. Quality of care for acute
asthma in 63 US emergency departments. J Allergy Clin
Immunol Feb 2009;123(2):354e61.
24. Ungar WJ, Davidson-Grimwood SR, Cousins M. Parents were
accurate proxy reporters of urgent pediatric asthma health
services: a retrospective agreement analysis. J Clin Epidemiol
2007;60(11):1176e83.
25. To T, Wang C, Dell S, et al. Risk factors for repeat adverse
asthma events in children after visiting an emergency depart-
ment. Ambul Pediatr 2008;8(5):281e7.
26. D’Agostino Jr RB. Propensity score methods for bias reduction
in the comparison of a treatment to a non-randomized control
group. Stat Med Oct 15 1998;17(19):2265e81.
27. SAS Institute Inc. SAS/STAT User’s Guide, Version 9, 2006.
28. Mackey D, Myles M, Spooner CH, et al. Changing the process of
care and practice in acute asthma in the emergency depart-
ment: experience with an asthma care map in a regional
hospital. CJEM 2007;9(5):353e65.29. Doing the most to ensure the least emergency department
asthma visits: asthma experts consider preliminary project
findings. Pediatrics 2006;117(4 Pt 2):S159eS166.
30. Singer AJ, Camargo Jr CA, Lampell M, et al. A call for
expanding the role of the emergency physician in the care of
patients with asthma. Ann Emerg Med Mar 2005;45(3):295e8.
31. Gervais P, Larouche I, Blais L, Fillion A, Beauchesne MF. Asthma
management at discharge from the emergency department:
a descriptive study. Can Respir J 2005;12(4):219e22.
32. Worster A, Bledsoe RD, Cleve P, Fernandes CM, Upadhye S,
Eva K. Reassessing the methods of medical record review
studies in emergency medicine research. Ann Emerg Med 2005;
45(4):448e51.
33. McDermott MF, Lenhardt RO, Catrambone CD, Walter J,
Weiss KB. Adequacy of medical chart review to characterize
emergency care for asthma: findings from the Illinois emer-
gency department Asthma collaborative. Acad Emerg Med
2006;13(3):345e8.
34. Zorc JJ, Scarfone RJ, Li Y, et al. Scheduled follow-up after
a pediatric emergency department visit for asthma:
a randomized trial. Pediatrics Mar 2003;111(3):495e502.
35. Baren JM, Boudreaux ED, Brenner BE, et al. Randomized
controlled trial of emergency department interventions to
improve primary care follow-up for patients with acute
asthma. Chest 2006;129(2):257e65.
36. Sin DD, Bell NR, Man SFP. Effects of increased primary care
access on process of care and health outcomes among patients
with asthma who frequent emergency departments. Am J Med
2004;117(7):479e83.
